{
  "description": "MedDRA codes that represent the specific transfusion adverse events that are considered by this Implementation Guide",
  "_filename": "ValueSet-MedDRATransfusionAdverseEventVS.json",
  "package_name": "hl7.fhir.us.icsr-ae-reporting",
  "date": "2023-08-29T21:18:01+00:00",
  "publisher": "Biomedical Research & Regulation WG",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166",
      "display": "United States of America"
    } ]
  } ],
  "name": "MedDRATransfusionAdverseEventVS",
  "copyright": "MedDRA® is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations.  All rights reserved.",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "title": "Transfusion-related Adverse Events",
  "package_version": "1.0.1",
  "status": "draft",
  "id": "2a99c923-d10c-41bf-9abb-ca56f6e886a9",
  "kind": null,
  "url": "http://hl7.org/fhir/us/icsr-ae-reporting/ValueSet/MedDRATransfusionAdverseEventVS",
  "version": "1.0.1",
  "contact": [ {
    "name": "Biomedical Research & Regulation WG",
    "telecom": [ {
      "value": "http://hl7.org/Special/committees/rcrim",
      "system": "url"
    } ]
  }, {
    "name": "Jean Duteau",
    "telecom": [ {
      "value": "mailto:jean.duteau@ibm.com",
      "system": "email"
    } ]
  } ]
}